Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
J
JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
TSE:4552
Price:
502
JPY
1.01%
Market Closed
Market Cap:
¥65.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
JP |
|
E
|
Entergy Corp
SWB:ETY
|
US |
|
Intesa Sanpaolo SpA
OTC:IITSF
|
IT |
|
P
|
Planktos Corp
OTC:PLKT
|
US |
|
A
|
Agilent Technologies Inc
F:AG8
|
US |
|
Endeavour Mining plc
TSX:EDV
|
UK |
|
Matas A/S
CSE:MATAS
|
DK |
Wall St Price Targets
Price Forecast
Based on 8 analysts
Based on 8 analysts
+10% Upside
from
¥502
today
JCR Pharmaceuticals Co Ltd (4552)’s 12-month stock price forecast through September 2027 has a consensus target of ¥550.8, implying 10% upside. The forecast is based on price targets from 8 Wall Street analysts.
JCR Pharmaceuticals Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JCR Pharmaceuticals Co Ltd's stock price target?
Price Target
550.8
JPY
550.8
JPY
According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 550.8 JPY with a low forecast of 454.5 JPY and a high forecast of 945 JPY.
What is the Revenue forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 3%.
What is the Pre-Tax Income forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
200%
200%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 200%.
What is the Net Income forecast for JCR Pharmaceuticals Co Ltd?
Projected CAGR
212%
212%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 212%.